| 005737/0041/m1/eu/10-cover/ema/ema-cover-final-redactions.pdf |
558 KB |
| 005737/0041/m1/eu/10-cover/ema/ema-cover-annex-documentlist.pdf |
206 KB |
| 005737/0041/m1/eu/19-clinical-trials/clinicaltrials-anonymisation-report-covid19vaccinejanssen.pdf |
105 KB |
| 005737/0041/m2/25-clin-over/m25-clinical-overview.pdf |
17 MB |
| 005737/0041/m2/27-clin-sum/m274-summary-clin-safety.pdf |
1 MB |
| 005737/0041/m5/53-clin-stud-rep/531-rep-biopharm-stud/5311-ba-stud-rep/vac31518cov1001/m5311-cov1001-s-interim-csr.pdf |
12.3 MB |
| 005737/0041/m5/53-clin-stud-rep/531-rep-biopharm-stud/5311-ba-stud-rep/vac31518cov1001/m5311-cov1001-s-interim-csr-supporting-data.pdf |
62.8 MB |
| 005737/0041/m5/53-clin-stud-rep/531-rep-biopharm-stud/5311-ba-stud-rep/vac31518cov1001/m5311-cov1001-s-interim-csr-addendum.pdf |
1.6 MB |
| 005737/0041/m5/53-clin-stud-rep/531-rep-biopharm-stud/5311-ba-stud-rep/vac31518cov1001/m5311-cov1001-s-app1611-protocol.pdf |
7 MB |
| 005737/0041/m5/53-clin-stud-rep/531-rep-biopharm-stud/5311-ba-stud-rep/vac31518cov1001/m5311-cov1001-s-app1619-sap.pdf |
787 KB |
| 005737/0041/m5/53-clin-stud-rep/531-rep-biopharm-stud/5311-ba-stud-rep/vac31518cov1001/m5311-cov1001-s-narratives.pdf |
794 KB |
| 005737/0041/m5/53-clin-stud-rep/531-rep-biopharm-stud/5311-ba-stud-rep/vac31518cov1001/m5311-cov1001-s-listing-serious-ae.pdf |
577 KB |
| 005737/0041/m5/53-clin-stud-rep/531-rep-biopharm-stud/5311-ba-stud-rep/vac31518cov1001/m5311-cov1001-s-listing-severe-ae.pdf |
595 KB |
| 005737/0041/m5/53-clin-stud-rep/531-rep-biopharm-stud/5311-ba-stud-rep/vac31518cov1001/m5311-cov1001-s-ae-listings.pdf |
2 MB |
| 005737/0041/m5/53-clin-stud-rep/531-rep-biopharm-stud/5311-ba-stud-rep/vac31518cov1001/m5311-cov1001-s-immunogenicity.pdf |
4.6 MB |
| 005737/0041/m5/53-clin-stud-rep/531-rep-biopharm-stud/5311-ba-stud-rep/vac31518cov1002/m5311-cov1002-s-topline-immunogenicity.pdf |
1.2 MB |
| 005737/0041/m5/53-clin-stud-rep/531-rep-biopharm-stud/5311-ba-stud-rep/vac31518cov1002/m5311-cov1002-s-topline-safety.pdf |
1.1 MB |
| 005737/0041/m5/53-clin-stud-rep/531-rep-biopharm-stud/5311-ba-stud-rep/vac31518cov1002/m5311-cov1002-s-app1611-protocol.pdf |
804 KB |
| 005737/0041/m5/53-clin-stud-rep/531-rep-biopharm-stud/5311-ba-stud-rep/vac31518cov1002/m5311-cov1002-s-app1619-sap.pdf |
280 KB |
| 005737/0041/m5/53-clin-stud-rep/531-rep-biopharm-stud/5311-ba-stud-rep/vac31518cov1002/m5311-cov1002-s-narratives.pdf |
1.1 MB |
| 005737/0041/m5/53-clin-stud-rep/531-rep-biopharm-stud/5311-ba-stud-rep/vac31518cov1002/m5311-cov1002-s-listing-serious-ae.pdf |
599 KB |
| 005737/0041/m5/53-clin-stud-rep/531-rep-biopharm-stud/5311-ba-stud-rep/vac31518cov1002/m5311-cov1002-s-listing-severe-ae.pdf |
592 KB |
| 005737/0041/m5/53-clin-stud-rep/531-rep-biopharm-stud/5311-ba-stud-rep/vac31518cov2001/m5311-cov2001-s-interim-csr.pdf |
4.1 MB |
| 005737/0041/m5/53-clin-stud-rep/531-rep-biopharm-stud/5311-ba-stud-rep/vac31518cov2001/m5311-cov2001-s-interim-csr-supporting-data.pdf |
5.5 MB |
| 005737/0041/m5/53-clin-stud-rep/531-rep-biopharm-stud/5311-ba-stud-rep/vac31518cov2001/m5311-cov2001-s-app1611-protocol.pdf |
2.6 MB |
| 005737/0041/m5/53-clin-stud-rep/531-rep-biopharm-stud/5311-ba-stud-rep/vac31518cov2001/m5311-cov2001-s-app1619-sap.pdf |
369 KB |
| 005737/0041/m5/53-clin-stud-rep/531-rep-biopharm-stud/5311-ba-stud-rep/vac31518cov2001/m5311-cov2001-s-narratives.pdf |
879 KB |
| 005737/0041/m5/53-clin-stud-rep/531-rep-biopharm-stud/5311-ba-stud-rep/vac31518cov2001/m5311-cov2001-s-listing-serious-ae.pdf |
602 KB |
| 005737/0041/m5/53-clin-stud-rep/531-rep-biopharm-stud/5311-ba-stud-rep/vac31518cov2001/m5311-cov2001-s-listing-severe-ae.pdf |
593 KB |
| 005737/0041/m5/53-clin-stud-rep/535-rep-effic-safety-stud/covid-19/5351-stud-rep-contr/vac31518cov3001/m5351-cov3001-p-interim-csr-prim-analysis.pdf |
30.4 MB |
| 005737/0041/m5/53-clin-stud-rep/535-rep-effic-safety-stud/covid-19/5351-stud-rep-contr/vac31518cov3001/m5351-cov3001-p-interim-csr-prim-analysis-supporting-data.pdf |
66 MB |
| 005737/0041/m5/53-clin-stud-rep/535-rep-effic-safety-stud/covid-19/5351-stud-rep-contr/vac31518cov3001/m5351-cov3001-p-interim-csr-prim-analysis-addendum.pdf |
2.8 MB |
| 005737/0041/m5/53-clin-stud-rep/535-rep-effic-safety-stud/covid-19/5351-stud-rep-contr/vac31518cov3001/m5351-cov3001-p-app1611-protocol.pdf |
6.4 MB |
| 005737/0041/m5/53-clin-stud-rep/535-rep-effic-safety-stud/covid-19/5351-stud-rep-contr/vac31518cov3001/m5351-cov3001-p-app1619-sap.pdf |
1.6 MB |
| 005737/0041/m5/53-clin-stud-rep/535-rep-effic-safety-stud/covid-19/5351-stud-rep-contr/vac31518cov3001/m5351-cov3001-p-viral-seq-report.pdf |
1 MB |
| 005737/0041/m5/53-clin-stud-rep/535-rep-effic-safety-stud/covid-19/5351-stud-rep-contr/vac31518cov3001/m5351-cov3001-p-narratives-note-reviewer.pdf |
631 KB |
| 005737/0041/m5/53-clin-stud-rep/535-rep-effic-safety-stud/covid-19/5351-stud-rep-contr/vac31518cov3001/m5351-cov3001-p-narratives-tab1.pdf |
12.6 MB |
| 005737/0041/m5/53-clin-stud-rep/535-rep-effic-safety-stud/covid-19/5351-stud-rep-contr/vac31518cov3001/m5351-cov3001-p-narratives-tab2.pdf |
15.5 MB |
| 005737/0041/m5/53-clin-stud-rep/535-rep-effic-safety-stud/covid-19/5351-stud-rep-contr/vac31518cov3001/m5351-cov3001-p-patient-profiles.pdf |
16.1 MB |
| 005737/0041/m5/53-clin-stud-rep/535-rep-effic-safety-stud/covid-19/5351-stud-rep-contr/vac31518cov3001/m5351-cov3001-p-ae-listings.pdf |
1.4 MB |
| 005737/0041/m5/53-clin-stud-rep/535-rep-effic-safety-stud/covid-19/5351-stud-rep-contr/vac31518cov3001/m5351-cov3001-p-listing-hospitalizations.pdf |
635 KB |
| 005737/0041/m5/53-clin-stud-rep/535-rep-effic-safety-stud/covid-19/5351-stud-rep-contr/vac31518cov3001/m5351-cov3001-p-add-stat-outputs-batch1.pdf |
3.3 MB |
| 005737/0041/m5/53-clin-stud-rep/535-rep-effic-safety-stud/covid-19/5351-stud-rep-contr/vac31518cov3001/m5351-cov3001-p-add-stat-outputs-batch2.pdf |
3 MB |
| 005737/0041/m5/53-clin-stud-rep/535-rep-effic-safety-stud/covid-19/5351-stud-rep-contr/vac31518cov3001/m5351-cov3001-p-aesi-safety-narratives.pdf |
11.1 MB |
| 005737/0041/m5/53-clin-stud-rep/535-rep-effic-safety-stud/covid-19/5351-stud-rep-contr/vac31518cov3001/m5351-cov3001-p-safety-narratives-asthma.pdf |
1.2 MB |
| 005737/0041/m5/53-clin-stud-rep/535-rep-effic-safety-stud/covid-19/5351-stud-rep-contr/vac31518cov3001/m5351-cov3001-p-msr.pdf |
2.5 MB |
| 005737/0041/m5/53-clin-stud-rep/535-rep-effic-safety-stud/covid-19/5351-stud-rep-contr/vac31518cov3009/m5351-cov3009-s-app1611-protocol.pdf |
2.2 MB |
| 005737/0041/m5/53-clin-stud-rep/535-rep-effic-safety-stud/covid-19/5351-stud-rep-contr/vac31518cov3009/m5351-cov3009-s-narratives.pdf |
739 KB |
| 005737/0041/m5/53-clin-stud-rep/535-rep-effic-safety-stud/covid-19/5351-stud-rep-contr/vac31518cov3009/m5351-cov3009-s-listing-serious-ae.pdf |
572 KB |
| 005737/0041/m5/53-clin-stud-rep/535-rep-effic-safety-stud/covid-19/5351-stud-rep-contr/vac31518cov3009/m5351-cov3009-s-app1619-sap.pdf |
1.4 MB |
| 005737/0041/m5/53-clin-stud-rep/535-rep-effic-safety-stud/covid-19/5351-stud-rep-contr/vac31518cov2004/m5351-cov2004-s-app1611-protocol.pdf |
3.3 MB |
| 005737/0041/m5/53-clin-stud-rep/535-rep-effic-safety-stud/covid-19/5354-other-stud-rep/advac/m5354-advac-s-advac-safety-database-v5-0.pdf |
29.8 MB |
| 005737/0041/m5/53-clin-stud-rep/535-rep-effic-safety-stud/covid-19/5354-other-stud-rep/advac/m5354-advac-s-seroprevalence.pdf |
1.5 MB |
| 005737/0041/m5/53-clin-stud-rep/535-rep-effic-safety-stud/covid-19/5354-other-stud-rep/advac/m5354-advac-s-natural-pre-existing-immunity.pdf |
862 KB |
| 005737/0041/m5/53-clin-stud-rep/535-rep-effic-safety-stud/covid-19/5354-other-stud-rep/advac/m5354-advac-s-review-saes.pdf |
1.4 MB |
| 005737/0041/m5/53-clin-stud-rep/535-rep-effic-safety-stud/covid-19/5354-other-stud-rep/advac/m5354-advac-s-review-pregnancies.pdf |
1.4 MB |
| 005737/0041/m5/53-clin-stud-rep/535-rep-effic-safety-stud/covid-19/5354-other-stud-rep/advac/m5354-advac-s-cum-safety-review-neuroinflammatory-aes.pdf |
1.6 MB |
| 005737/0041/index-md5.txt |
32 B |
| 005737/0041/index.xml |
40 KB |
| 005737/0041/m1/eu/eu-regional.xml |
3 KB |
| 005737/0041/util/style/ectd-2-0.xsl |
2 KB |
| 005737/0041/util/style/eu-regional.xsl |
25 KB |
| 005737/0041/util/dtd/eu-regional.dtd |
5 KB |
| 005737/0041/util/dtd/eu-leaf.mod |
2 KB |
| 005737/0041/util/dtd/eu-envelope.mod |
3 KB |
| 005737/0041/util/dtd/ich-ectd-3-2.dtd |
31 KB |
Magnet link
